88 related articles for article (PubMed ID: 16198424)
1. A simplified probe preparation for ELISA-based NF-kappaB activity assay.
Jin S; Lu D; Ye S; Ye H; Zhu L; Feng Z; Liu S; Wang D; Hu Q
J Biochem Biophys Methods; 2005 Oct; 65(1):20-9. PubMed ID: 16198424
[TBL] [Abstract][Full Text] [Related]
2. [Development of molecular pathology analysis testing which can be practiced in the hospital laboratory. The clinical application of a transcription factor activation test].
Kitajima I
Rinsho Byori; 2007 Mar; 55(3):262-71. PubMed ID: 17441471
[TBL] [Abstract][Full Text] [Related]
3. Label-free quantification of activated NF-kappaB in biological samples by atomic force microscopy.
Menotta M; Crinelli R; Carloni E; Bianchi M; Giacomini E; Valbusa U; Magnani M
Biosens Bioelectron; 2010 Jul; 25(11):2490-6. PubMed ID: 20452198
[TBL] [Abstract][Full Text] [Related]
4. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.
Griffin BD; Moynagh PN
Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530
[TBL] [Abstract][Full Text] [Related]
5. In silico identification of NF-kappaB-regulated genes in pancreatic beta-cells.
Naamane N; van Helden J; Eizirik DL
BMC Bioinformatics; 2007 Feb; 8():55. PubMed ID: 17302974
[TBL] [Abstract][Full Text] [Related]
6. Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.
Taggart CC; Cryan SA; Weldon S; Gibbons A; Greene CM; Kelly E; Low TB; O'neill SJ; McElvaney NG
J Exp Med; 2005 Dec; 202(12):1659-68. PubMed ID: 16352738
[TBL] [Abstract][Full Text] [Related]
7. Development of a cell death-based method for the screening of nuclear factor-kappaB inhibitors.
Chopra P; Bajpai M; Dastidar SG; Ray A
J Immunol Methods; 2008 Jun; 335(1-2):126-31. PubMed ID: 18430434
[TBL] [Abstract][Full Text] [Related]
8. 4-O-methylgallic acid down-regulates endothelial adhesion molecule expression by inhibiting NF-kappaB-DNA-binding activity.
Lee G; Na HJ; Namkoong S; Jeong Kwon H; Han S; Ha KS; Kwon YG; Lee H; Kim YM
Eur J Pharmacol; 2006 Dec; 551(1-3):143-51. PubMed ID: 17027748
[TBL] [Abstract][Full Text] [Related]
9. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
10. Analysis of interleukin-1beta-modulated mRNA gene transcription in human gingival keratinocytes by epithelia-specific cDNA microarrays.
Steinberg T; Dannewitz B; Tomakidi P; Hoheisel JD; Müssig E; Kohl A; Nees M
J Periodontal Res; 2006 Oct; 41(5):426-46. PubMed ID: 16953820
[TBL] [Abstract][Full Text] [Related]
11. A new oligonucleotide-based ELISA for the detection of anti-double-stranded DNA antibodies.
Radice A; Sinico RA
Autoimmunity; 2006 Mar; 39(2):113-9. PubMed ID: 16698667
[TBL] [Abstract][Full Text] [Related]
12. An optimized assay for transcription factor NF-kappaB with dsDNA-coupled microplate.
Li JL; Chen Hm; Li Ml; Hua D; Lu Zh; Wang Jk
Colloids Surf B Biointerfaces; 2007 Mar; 55(1):31-7. PubMed ID: 17194575
[TBL] [Abstract][Full Text] [Related]
13. Exo-Dye-based assay for rapid, inexpensive, and sensitive detection of DNA-binding proteins.
Chen Z; Ji M; Hou P; Lu Z
Biochem Biophys Res Commun; 2006 Jul; 345(3):1254-63. PubMed ID: 16716262
[TBL] [Abstract][Full Text] [Related]
14. Involvement of spinal cord nuclear factor kappaB activation in rat models of proinflammatory cytokine-mediated pain facilitation.
Ledeboer A; Gamanos M; Lai W; Martin D; Maier SF; Watkins LR; Quan N
Eur J Neurosci; 2005 Oct; 22(8):1977-86. PubMed ID: 16262636
[TBL] [Abstract][Full Text] [Related]
15. The effect of 17beta-estradiol on IL-6 secretion and NF-kappaB DNA-binding activity in human retinal pigment epithelial cells.
Paimela T; Ryhänen T; Mannermaa E; Ojala J; Kalesnykas G; Salminen A; Kaarniranta K
Immunol Lett; 2007 Jun; 110(2):139-44. PubMed ID: 17532054
[TBL] [Abstract][Full Text] [Related]
16. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells.
Matsukura S; Kokubu F; Kurokawa M; Kawaguchi M; Ieki K; Kuga H; Odaka M; Suzuki S; Watanabe S; Takeuchi H; Kasama T; Adachi M
Clin Exp Allergy; 2006 Aug; 36(8):1049-62. PubMed ID: 16911361
[TBL] [Abstract][Full Text] [Related]
17. Eriocalyxin B inhibits nuclear factor-kappaB activation by interfering with the binding of both p65 and p50 to the response element in a noncompetitive manner.
Leung CH; Grill SP; Lam W; Gao W; Sun HD; Cheng YC
Mol Pharmacol; 2006 Dec; 70(6):1946-55. PubMed ID: 16940413
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-kappaB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemia.
Jenkins C; Hewamana S; Gilkes A; Neelakantan S; Crooks P; Mills K; Pepper C; Burnett A
Br J Haematol; 2008 Dec; 143(5):661-71. PubMed ID: 19036014
[TBL] [Abstract][Full Text] [Related]
19. BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-kappaB activity.
Clemo NK; Collard TJ; Southern SL; Edwards KD; Moorghen M; Packham G; Hague A; Paraskeva C; Williams AC
Carcinogenesis; 2008 Apr; 29(4):849-57. PubMed ID: 18204076
[TBL] [Abstract][Full Text] [Related]
20. A functional NF-kappaB enhancer element in the first intron contributes to the control of c-fos transcription.
Charital YM; van Haasteren G; Massiha A; Schlegel W; Fujita T
Gene; 2009 Feb; 430(1-2):116-22. PubMed ID: 19026727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
